Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Intrahost cytomegalovirus population genetics following antibody pretreatment in a monkey model of congenital transmission.

Vera Cruz D, Nelson CS, Tran D, Barry PA, Kaur A, Koelle K, Permar SR.

PLoS Pathog. 2020 Feb 14;16(2):e1007968. doi: 10.1371/journal.ppat.1007968. [Epub ahead of print]

2.

Real-time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study.

Barrow-McGee R, Procter J, Owen J, Woodman N, Lombardelli C, Kothari A, Kovacs T, Douek M, George S, Barry PA, Ramsey K, Gibson A, Buus R, Holgersen E, Natrajan R, Haider S, Shattock MJ, Gillett C, Tutt AN, Pinder SE, Naidoo K.

J Pathol. 2020 Mar;250(3):262-274. doi: 10.1002/path.5367. Epub 2019 Dec 22.

PMID:
31755096
3.

Cytomegalovirus-vectored vaccines for HIV and other pathogens.

Barry PA, Deere JD, Yue Y, Chang WWL, Schmidt KA, Wussow F, Chiuppesi F, Diamond DJ, Sparger EE, Walter MR, Hartigan-O'Connor DJ.

AIDS. 2020 Mar 1;34(3):335-349. doi: 10.1097/QAD.0000000000002396.

PMID:
31634191
4.

Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.

Deere JD, Chang WLW, Villalobos A, Schmidt KA, Deshpande A, Castillo LD, Fike J, Walter MR, Barry PA, Hartigan-O'Connor DJ.

Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):13036-13041. doi: 10.1073/pnas.1903317116. Epub 2019 Jun 12.

5.

Suspected Exposure to Filoviruses Among People Contacting Wildlife in Southwestern Uganda.

Smiley Evans T, Tutaryebwa L, Gilardi KV, Barry PA, Marzi A, Eberhardt M, Ssebide B, Cranfield MR, Mugisha O, Mugisha E, Kellermann S, Mazet JAK, Johnson CK.

J Infect Dis. 2018 Nov 22;218(suppl_5):S277-S286. doi: 10.1093/infdis/jiy251.

6.

Validation of the Vectra XT three-dimensional imaging system for measuring breast volume and symmetry following oncological reconstruction.

O'Connell RL, Khabra K, Bamber JC, deSouza N, Meybodi F, Barry PA, Rusby JE.

Breast Cancer Res Treat. 2018 Sep;171(2):391-398. doi: 10.1007/s10549-018-4843-6. Epub 2018 Jun 5.

7.

Subclinical Cytomegalovirus Infection Is Associated with Altered Host Immunity, Gut Microbiota, and Vaccine Responses.

Santos Rocha C, Hirao LA, Weber MG, Méndez-Lagares G, Chang WLW, Jiang G, Deere JD, Sparger EE, Roberts J, Barry PA, Hartigan-O'Connor DJ, Dandekar S.

J Virol. 2018 Jun 13;92(13). pii: e00167-18. doi: 10.1128/JVI.00167-18. Print 2018 Jul 1.

8.

Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complex.

Wussow F, Chiuppesi F, Meng Z, Martinez J, Nguyen J, Barry PA, Diamond DJ.

J Virol Methods. 2018 Jan;251:30-37. doi: 10.1016/j.jviromet.2017.10.006. Epub 2017 Oct 6.

9.

Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.

Itell HL, Kaur A, Deere JD, Barry PA, Permar SR.

Curr Opin Virol. 2017 Aug;25:126-133. doi: 10.1016/j.coviro.2017.08.005. Epub 2017 Sep 6. Review.

10.

Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.

Chiuppesi F, Wussow F, Scharf L, Contreras H, Gao H, Meng Z, Nguyen J, Barry PA, Bjorkman PJ, Diamond DJ.

PLoS One. 2017 Aug 16;12(8):e0183377. doi: 10.1371/journal.pone.0183377. eCollection 2017.

11.

Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants.

Smiley Evans T, Lowenstine LJ, Gilardi KV, Barry PA, Ssebide BJ, Kinani JF, Nizeyimana F, Noheri JB, Cranfield MR, Mudakikwa A, Goldstein T, Mazet JAK, Johnson CK.

Sci Rep. 2017 Jul 13;7(1):5352. doi: 10.1038/s41598-017-04877-1.

12.

Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.

Nelson CS, Cruz DV, Tran D, Bialas KM, Stamper L, Wu H, Gilbert M, Blair R, Alvarez X, Itell H, Chen M, Deshpande A, Chiuppesi F, Wussow F, Diamond DJ, Vandergrift N, Walter MR, Barry PA, Cohen-Wolkowiez M, Koelle K, Kaur A, Permar SR.

JCI Insight. 2017 Jul 6;2(13). pii: 94002. doi: 10.1172/jci.insight.94002. eCollection 2017 Jul 6.

13.

The potential role of three-dimensional surface imaging as a tool to evaluate aesthetic outcome after Breast Conserving Therapy (BCT).

O'Connell RL, Di Micco R, Khabra K, Wolf L, deSouza N, Roche N, Barry PA, Kirby AM, Rusby JE.

Breast Cancer Res Treat. 2017 Jul;164(2):385-393. doi: 10.1007/s10549-017-4256-y. Epub 2017 Apr 26.

14.

Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission.

Fan Q, Nelson CS, Bialas KM, Chiuppesi F, Amos J, Gurley TC, Marshall DJ, Eudailey J, Heimsath H, Himes J, Deshpande A, Walter MR, Wussow F, Diamond DJ, Barry PA, Moody MA, Kaur A, Permar SR.

Clin Vaccine Immunol. 2017 May 5;24(5). pii: e00510-16. doi: 10.1128/CVI.00510-16. Print 2017 May.

15.

Changes in Circulating B Cell Subsets Associated with Aging and Acute SIV Infection in Rhesus Macaques.

Chang WL, Gonzalez DF, Kieu HT, Castillo LD, Messaoudi I, Shen X, Tomaras GD, Shacklett BL, Barry PA, Sparger EE.

PLoS One. 2017 Jan 17;12(1):e0170154. doi: 10.1371/journal.pone.0170154. eCollection 2017.

16.

Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.

Chiuppesi F, Kaltcheva T, Meng Z, Barry PA, Diamond DJ, Wussow F.

J Virol. 2017 Feb 28;91(6). pii: e01857-16. doi: 10.1128/JVI.01857-16. Print 2017 Mar 15.

17.

Standard wide local excision or bilateral reduction mammoplasty in large-breasted women with small tumours: Surgical and patient-reported outcomes.

Di Micco R, O'Connell RL, Barry PA, Roche N, MacNeill FA, Rusby JE.

Eur J Surg Oncol. 2017 Apr;43(4):636-641. doi: 10.1016/j.ejso.2016.10.027. Epub 2016 Nov 17.

PMID:
27908586
18.

Detection of viruses using discarded plants from wild mountain gorillas and golden monkeys.

Smiley Evans T, Gilardi KV, Barry PA, Ssebide BJ, Kinani JF, Nizeyimana F, Noheri JB, Byarugaba DK, Mudakikwa A, Cranfield MR, Mazet JA, Johnson CK.

Am J Primatol. 2016 Nov;78(11):1222-1234. doi: 10.1002/ajp.22576. Epub 2016 Jun 22.

19.

Bilateral mammoplasty for cancer: Surgical, oncological and patient-reported outcomes.

Di Micco R, O'Connell RL, Barry PA, Roche N, MacNeill FA, Rusby JE.

Eur J Surg Oncol. 2017 Jan;43(1):68-75. doi: 10.1016/j.ejso.2016.08.013. Epub 2016 Sep 9.

PMID:
27692851
20.

Initial experience of the BREAST-Q breast-conserving therapy module.

O'Connell RL, DiMicco R, Khabra K, O'Flynn EA, deSouza N, Roche N, Barry PA, Kirby AM, Rusby JE.

Breast Cancer Res Treat. 2016 Nov;160(1):79-89. Epub 2016 Sep 16.

PMID:
27637781
21.

Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.

Eberhardt MK, Deshpande A, Fike J, Short R, Schmidt KA, Blozis SA, Walter MR, Barry PA.

J Virol. 2016 Oct 14;90(21):9920-9930. doi: 10.1128/JVI.00635-16. Print 2016 Nov 1.

22.

Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS.

Deere JD, Chang WL, Castillo LD, Schmidt KA, Kieu HT, Renzette N, Kowalik T, Barthold SW, Shacklett BL, Barry PA, Sparger EE.

PLoS One. 2016 May 16;11(5):e0155629. doi: 10.1371/journal.pone.0155629. eCollection 2016.

23.

The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains.

Yue Y, Kaur A, Lilja A, Diamond DJ, Walter MR, Barry PA.

J Gen Virol. 2016 Jun;97(6):1426-1438. doi: 10.1099/jgv.0.000455. Epub 2016 Mar 14.

24.

Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.

Bialas KM, Tanaka T, Tran D, Varner V, Cisneros De La Rosa E, Chiuppesi F, Wussow F, Kattenhorn L, Macri S, Kunz EL, Estroff JA, Kirchherr J, Yue Y, Fan Q, Lauck M, O'Connor DH, Hall AH, Xavier A, Diamond DJ, Barry PA, Kaur A, Permar SR.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13645-50. doi: 10.1073/pnas.1511526112. Epub 2015 Oct 19.

25.

Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.

Chiuppesi F, Wussow F, Johnson E, Bian C, Zhuo M, Rajakumar A, Barry PA, Britt WJ, Chakraborty R, Diamond DJ.

J Virol. 2015 Dec;89(23):11884-98. doi: 10.1128/JVI.01701-15. Epub 2015 Sep 16.

26.

Editorial overview: Host pathogens: New paradigms and tools to decipher and deconstruct the host-pathogen interaction.

Silvestri G, Barry PA.

Curr Opin Immunol. 2015 Oct;36:v-viii. doi: 10.1016/j.coi.2015.08.004. Epub 2015 Sep 7. No abstract available.

PMID:
26359003
27.

Primary Systemic Treatment in the Management of Operable Breast Cancer: Best Surgical Approach for Diagnosis, Biological Evaluation, and Research.

Barry PA, Schiavon G.

J Natl Cancer Inst Monogr. 2015 May;2015(51):4-8. doi: 10.1093/jncimonographs/lgv008.

PMID:
26063876
28.

Optimization of a Novel Non-invasive Oral Sampling Technique for Zoonotic Pathogen Surveillance in Nonhuman Primates.

Smiley Evans T, Barry PA, Gilardi KV, Goldstein T, Deere JD, Fike J, Yee J, Ssebide BJ, Karmacharya D, Cranfield MR, Wolking D, Smith B, Mazet JA, Johnson CK.

PLoS Negl Trop Dis. 2015 Jun 5;9(6):e0003813. doi: 10.1371/journal.pntd.0003813. eCollection 2015.

29.

The interplay between immune maturation, age, chronic viral infection and environment.

Oxford KL, Dela Pena-Ponce MGA, Jensen K, Eberhardt MK, Spinner A, Van Rompay KK, Rigdon J, Mollan KR, Krishnan VV, Hudgens MG, Barry PA, De Paris K.

Immun Ageing. 2015 May 9;12:3. doi: 10.1186/s12979-015-0030-3. eCollection 2015.

30.

Exploiting viral natural history for vaccine development.

Barry PA.

Med Microbiol Immunol. 2015 Jun;204(3):255-62. doi: 10.1007/s00430-015-0406-1. Epub 2015 Mar 21. Review.

31.

Expression of recipient cytomegalovirus in immunosuppressed and xenotransplanted Macaca fascicularis may be related to more severe gastrointestinal lesions.

Cavicchioli L, Zanetti R, Ferraresso S, Crossan C, Barry PA, Boldrin M, Vadori M, Ferro S, Calabrese F, Scobie L, Cozzi E, Zappulli V.

Xenotransplantation. 2015 Mar-Apr;22(2):135-43. doi: 10.1111/xen.12153. Epub 2015 Feb 12.

PMID:
25683577
32.

Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.

Wussow F, Chiuppesi F, Martinez J, Campo J, Johnson E, Flechsig C, Newell M, Tran E, Ortiz J, La Rosa C, Herrmann A, Longmate J, Chakraborty R, Barry PA, Diamond DJ.

PLoS Pathog. 2014 Nov 20;10(11):e1004524. doi: 10.1371/journal.ppat.1004524. eCollection 2014 Nov.

33.

Human herpes simplex virus type 1 in confiscated gorilla.

Gilardi KV, Oxford KL, Gardner-Roberts D, Kinani JF, Spelman L, Barry PA, Cranfield MR, Lowenstine LJ.

Emerg Infect Dis. 2014 Nov;20(11):1883-6. doi: 10.3201/eid2011.140075.

34.

Pathogen manipulation of cIL-10 signaling pathways: opportunities for vaccine development?

Eberhardt MK, Barry PA.

Curr Top Microbiol Immunol. 2014;380:93-128. doi: 10.1007/978-3-662-43492-5_5. Review.

PMID:
25004815
35.

Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92.

Assaf BT, Mansfield KG, Strelow L, Westmoreland SV, Barry PA, Kaur A.

J Virol. 2014 Aug;88(16):9310-20. doi: 10.1128/JVI.00162-14. Epub 2014 Jun 4.

36.

Using the nonhuman primate model of HCMV to guide vaccine development.

Deere JD, Barry PA.

Viruses. 2014 Mar 27;6(4):1483-501. doi: 10.3390/v6041483. Review.

37.

Letter to the editor on 'Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial'.

Barry PA, Schiavon G, MacNeill FA.

Ann Oncol. 2014 Apr;25(4):909-10. doi: 10.1093/annonc/mdu030. Epub 2014 Mar 7. No abstract available.

38.

The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastases.

Schiavon G, Ruggiero A, Bekers DJ, Barry PA, Sleijfer S, Kloth J, Krestin GP, Schöffski P, Verweij J, Mathijssen RH.

Eur J Cancer. 2014 Mar;50(5):972-80. doi: 10.1016/j.ejca.2014.01.004. Epub 2014 Jan 27.

PMID:
24480402
39.

Sequencing the transcriptome of milk production: milk trumps mammary tissue.

Lemay DG, Hovey RC, Hartono SR, Hinde K, Smilowitz JT, Ventimiglia F, Schmidt KA, Lee JW, Islas-Trejo A, Silva PI, Korf I, Medrano JF, Barry PA, German JB.

BMC Genomics. 2013 Dec 12;14:872. doi: 10.1186/1471-2164-14-872.

40.

Efficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid/DNA adjuvant.

Carroll TD, Matzinger SR, Barry PA, McChesney MB, Fairman J, Miller CJ.

J Infect Dis. 2014 Jan 1;209(1):24-33. doi: 10.1093/infdis/jit540. Epub 2013 Oct 17.

41.

Vaccination against a virus-encoded cytokine significantly restricts viral challenge.

Eberhardt MK, Deshpande A, Chang WL, Barthold SW, Walter MR, Barry PA.

J Virol. 2013 Nov;87(21):11323-31. doi: 10.1128/JVI.01925-13. Epub 2013 Aug 14.

42.

Population dynamics of rhesus macaques and associated foamy virus in Bangladesh.

Feeroz MM, Soliven K, Small CT, Engel GA, Andreina Pacheco M, Yee JL, Wang X, Kamrul Hasan M, Oh G, Levine KL, Rabiul Alam SM, Craig KL, Jackson DL, Lee EG, Barry PA, Lerche NW, Escalante AA, Matsen Iv FA, Linial ML, Jones-Engel L.

Emerg Microbes Infect. 2013 May;2(5):e29. doi: 10.1038/emi.2013.23. Epub 2013 May 22.

43.

A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.

Wussow F, Yue Y, Martinez J, Deere JD, Longmate J, Herrmann A, Barry PA, Diamond DJ.

J Virol. 2013 Feb;87(3):1322-32. doi: 10.1128/JVI.01669-12. Epub 2012 Nov 14.

44.

Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1.

Malouli D, Nakayasu ES, Viswanathan K, Camp DG 2nd, Chang WL, Barry PA, Smith RD, Früh K.

J Virol. 2012 Sep;86(17):8959-73. doi: 10.1128/JVI.01132-12. Epub 2012 Jun 20.

45.

Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.

Eberhardt MK, Chang WL, Logsdon NJ, Yue Y, Walter MR, Barry PA.

PLoS One. 2012;7(5):e37931. doi: 10.1371/journal.pone.0037931. Epub 2012 May 24.

46.

Use of specific-pathogen-free (SPF) rhesus macaques to better model oral pediatric cytomegalovirus infection.

dela Pena MG, Strelow L, Barry PA, Abel K.

J Med Primatol. 2012 Jun;41(3):225-9. doi: 10.1111/j.1600-0684.2012.00541.x.

47.

Patterns of acute rhesus cytomegalovirus (RhCMV) infection predict long-term RhCMV infection.

Assaf BT, Mansfield KG, Westmoreland SV, Kaur A, Oxford KL, Diamond DJ, Barry PA.

J Virol. 2012 Jun;86(11):6354-7. doi: 10.1128/JVI.00607-12. Epub 2012 Apr 4.

48.

Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus.

Logsdon NJ, Eberhardt MK, Allen CE, Barry PA, Walter MR.

PLoS One. 2011;6(11):e28127. doi: 10.1371/journal.pone.0028127. Epub 2011 Nov 21.

49.
50.

Open reading frames carried on UL/b' are implicated in shedding and horizontal transmission of rhesus cytomegalovirus in rhesus monkeys.

Oxford KL, Strelow L, Yue Y, Chang WL, Schmidt KA, Diamond DJ, Barry PA.

J Virol. 2011 May;85(10):5105-14. doi: 10.1128/JVI.02631-10. Epub 2011 Mar 9.

Supplemental Content

Loading ...
Support Center